ETPrime

Jubilant Life - Jubilant Pharmova Share Price

  • 1,076.20-2.10 (-0.20%)
  • Volume: 4,44,676
  • Closed
  • Last Updated On: 15 Oct, 2025, 03:43 PM IST
High: "1500.00",Open: "1359.00",Low: "1206.00",
  • 1D
  • 1W
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Loading...
Jubilant Life - Jubilant Pharmova Share Price
  • 1,076.20-2.10 (-0.20%)
  • Volume: 4,44,676
Advertisment
Stock Recommendations

  • Potential
    Upside

  • 1 Year
    Target

BUY

Mean Recos by
4 Analysts

0

0

1

3

0

Strong Sell

Sell

Hold

Buy

Strong Buy

Unlock Potential Upside
Stock Reports Plus

/10

Stock Score

View Report
Earnings
Fundamentals
Relative Valuation
Risk
Price Momentum
No Rating (NR)
Negative
Neutral
Positive
Unlock Stock Score

Key Metrics

PE Ratio
(x)		37.25
EPS - TTM
(₹)		28.89
MCap
(₹ Cr.)		17,141.84
Sectoral MCap Rank
32
PB Ratio
(x)		2.75
Div Yield
(%)		0.46
Face Value
(₹)		1.00
Beta

Beta

1 Month0.68
3 Months0.67
6 Months0.42
1 Year0.69
3 Years1.09

0.68
VWAP
(₹)		1,059.38
52W H/L
(₹)
1,309.90 / 802.00

Jubilant Life share price insights

View All

  • In the last 20 years, only 3.38 % trading sessions saw intraday declines higher than 5 % .

  • Company delivered ROE of 13.41% in year ending Mar 31, 2025 outperforming its 5 year avg. of 7.75%. (Source: Consolidated Financials)

  • Company has spent 3.32% of its operating revenues towards interest expenses and 31.35% towards employee cost in the year ending Mar 31, 2025. (Source: Consolidated Financials)

  • 50 day moving crossover appeared on Oct 13, 2025. Average price decline of -6.02% within 30 days of this signal in last 5 years.

  • Jubilant Pharmova Ltd. share price moved down by -0.20% from its previous close of Rs 1,078.30. Jubilant Pharmova Ltd. stock last traded price is 1,076.20

    Share PriceValue
    Today/Current/Last1,076.20
    Previous Day1,078.301,078.00

InsightsJubilant Life

    Do you find these insights useful?

    • hate it

    • meh

    • love it

    Jubilant Life Share Price Returns

    1 Day-0.2%
    1 Week-0.91%
    1 Month-4.07%
    3 Months-10.51%
    1 Year-11.93%
    3 Years233.5%
    5 Years56.1%

    ET Stock ScreenersTop Score Companies

    Check whether Jubilant Life belongs to analysts' top-rated companies list?

    View Stock Screeners

    Jubilant Life News & Analysis

    View all Jubilant Life Share News & Announcements

    Jubilant Life Share Recommendations

    Recent Recos

    BUY

    Current

    Mean Recos by 4 Analysts

    Strong
    Sell    SellHoldBuyStrong
    Buy
    • Target₹570
    • OrganizationAxis Securities
    • BUY
    • Target₹474
    • OrganizationAnand Rathi
    • BUY

    Analyst Trends

    RatingsCurrent1 Week Ago1 Month Ago3 Months Ago
    Strong Buy---1
    Buy3333
    Hold111-
    Sell----
    Strong Sell----
    # Analysts4444
    View all Stock Recommendations

    Jubilant Life Financials

    • Insights

      • Employee & Interest Expense

        Company has spent 3.32% of its operating revenues towards interest expenses and 31.35% towards employee cost in the year ending Mar 31, 2025. (Source: Consolidated Financials)
      Quarterly | AnnualJun 2025Mar 2025Dec 2024Sep 2024Jun 2024
      Total Income1,912.701,940.701,830.901,774.001,745.70
      Total Income Growth (%)-1.446.003.211.62-1.54
      Total Expenses1,709.201,681.901,644.501,568.501,175.00
      Total Expenses Growth (%)1.622.274.8533.49-33.13
      EBIT203.50258.80186.40205.50570.70
      EBIT Growth (%)-21.3738.84-9.29-63.993,489.31
      Profit after Tax (PAT)102.90153.60100.90102.80482.10
      PAT Growth (%)-33.0152.23-1.85-78.68-
      EBIT Margin (%)10.6413.3410.1811.5832.69
      Net Profit Margin (%)5.387.915.515.7927.62
      Basic EPS (₹)6.499.716.376.4730.44
      Quarterly | AnnualJun 2025Mar 2025Dec 2024Sep 2024Jun 2024
      Total Income60.20235.20214.40209.50186.20
      Total Income Growth (%)-74.409.702.3412.51-27.24
      Total Expenses50.70204.70198.30185.10189.80
      Total Expenses Growth (%)-75.233.237.13-2.48-8.00
      EBIT9.5030.5016.1024.40-3.60
      EBIT Growth (%)-68.8589.44-34.02--107.26
      Profit after Tax (PAT)5.8013.605.3010.50-10.20
      PAT Growth (%)-57.35156.60-49.52--131.38
      EBIT Margin (%)15.7812.977.5111.65-1.93
      Net Profit Margin (%)9.635.782.475.01-5.48
      Basic EPS (₹)0.360.860.330.66-0.64
      Quarterly | Annual FY 2025 FY 2024 FY 2023 FY 2022 FY 2021
      Total Revenue7,291.306,771.606,320.066,141.456,116.17
      Total Revenue Growth (%)7.677.142.910.411.71
      Total Expenses6,669.706,456.306,247.715,501.025,235.12
      Total Expenses Growth (%)3.313.3413.575.085.39
      Profit after Tax (PAT)839.4077.10-60.98413.94835.87
      PAT Growth (%)988.72--114.73-50.48-6.94
      Operating Profit Margin (%)11.918.764.1412.8217.46
      Net Profit Margin (%)11.601.15-0.976.7513.70
      Basic EPS (₹)52.994.87-3.8326.0052.48
      Quarterly | Annual FY 2025 FY 2024 FY 2023 FY 2022 FY 2021
      Total Revenue845.30888.10948.01213.622,757.38
      Total Revenue Growth (%)-4.82-6.32343.79-92.25-16.77
      Total Expenses796.50846.40868.67131.372,484.21
      Total Expenses Growth (%)-5.90-2.56561.24-94.71-17.54
      Profit after Tax (PAT)19.2031.6049.8878.50214.48
      PAT Growth (%)-39.24-36.65-36.46-63.40-33.21
      Operating Profit Margin (%)10.549.1212.08128.5813.83
      Net Profit Margin (%)2.574.026.1589.467.91
      Basic EPS (₹)1.211.993.134.9313.47

      All figures in Rs Cr, unless mentioned otherwise

      View Details
    • Annual FY 2025 FY 2024 FY 2023 FY 2022 FY 2021
      Total Assets12,756.4011,548.5011,156.659,990.878,918.11
      Total Assets Growth (%)10.463.5111.6712.03-28.78
      Total Liabilities6,517.806,127.405,764.864,674.474,176.59
      Total Liabilities Growth (%)6.376.2923.3311.92-39.63
      Total Equity6,238.605,421.105,391.795,316.404,741.52
      Total Equity Growth (%)15.080.541.4212.12-15.39
      Current Ratio (x)1.652.052.122.202.82
      Total Debt to Equity (x)0.390.630.630.550.54
      Contingent Liabilities1,214.101,360.401,256.59842.82887.12
      Annual FY 2025 FY 2024 FY 2023 FY 2022 FY 2021
      Total Assets2,909.602,991.903,008.471,829.471,844.60
      Total Assets Growth (%)-2.75-0.5564.44-0.82-66.05
      Total Liabilities591.50617.40593.92547.65562.15
      Total Liabilities Growth (%)-4.203.958.45-2.58-80.11
      Total Equity2,318.102,374.502,414.551,281.821,282.45
      Total Equity Growth (%)-2.38-1.6688.37-0.05-50.81
      Current Ratio (x)1.561.711.601.270.55
      Total Debt to Equity (x)0.130.140.120.390.38
      Contingent Liabilities75.7092.00116.2669.7070.39

      All figures in Rs Cr, unless mentioned otherwise

      View Details
    • Annual FY 2025 FY 2024 FY 2023 FY 2022 FY 2021
      Net Cash flow from Operating Activities1,072.10971.30660.67837.541,784.27
      Net Cash used in Investing Activities487.70-607.90-544.41-380.37-739.01
      Net Cash flow from Financing Activities-1,452.70-432.50-156.68-32.60-1,709.39
      Net Cash Flow131.90-57.5030.10481.86-728.86
      Closing Cash & Cash Equivalent1,088.30956.401,013.92983.82501.96
      Closing Cash & Cash Equivalent Growth (%)13.79-5.673.0696.00-59.22
      Total Debt/ CFO (x)2.273.515.163.501.45
      Annual FY 2025 FY 2024 FY 2023 FY 2022 FY 2021
      Net Cash flow from Operating Activities135.60143.20-65.12-3.55608.38
      Net Cash used in Investing Activities-2.30-40.3031.0793.10177.96
      Net Cash flow from Financing Activities-156.80-77.8022.51-107.37-781.65
      Net Cash Flow-23.5025.10-11.53-17.82-56.38
      Closing Cash & Cash Equivalent12.6036.1010.9922.5140.33
      Closing Cash & Cash Equivalent Growth (%)-65.10228.39-51.15-44.19-58.30
      Total Debt/ CFO (x)2.262.39-4.63-140.480.81

      All figures in Rs Cr, unless mentioned otherwise

      View Details

    • Insights

      • ROE Outperforming 5 Year Average

        Company delivered ROE of 13.41% in year ending Mar 31, 2025 outperforming its 5 year avg. of 7.75%. (Source: Consolidated Financials)
      Annual FY 2025 FY 2024 FY 2023 FY 2022 FY 2021
      Return on Equity (%)13.411.41-1.127.7817.62
      Return on Capital Employed (%)8.136.082.779.3513.53
      Return on Assets (%)6.580.66-0.544.149.37
      Interest Coverage Ratio (x)5.123.564.338.035.79
      Asset Turnover Ratio (x)0.600.590.590.0268.38
      Price to Earnings (x)16.81117.65-72.9914.9312.97
      Price to Book (x)2.251.650.821.162.28
      EV/EBITDA (x)12.5411.798.386.959.01
      EBITDA Margin (%)17.0014.4612.9619.0423.18
      Annual FY 2025 FY 2024 FY 2023 FY 2022 FY 2021
      Return on Equity (%)0.821.332.066.1216.72
      Return on Capital Employed (%)3.022.673.696.2921.74
      Return on Assets (%)0.651.051.654.2911.62
      Interest Coverage Ratio (x)4.424.017.623.893.68
      Asset Turnover Ratio (x)0.250.260.330.05146.88
      Price to Earnings (x)769.23294.1289.2978.7450.76
      Price to Book (x)6.123.811.844.828.45
      EV/EBITDA (x)110.0077.9533.5655.8823.77
      EBITDA Margin (%)17.6615.2717.41135.7017.52

    Financial InsightsJubilant Life

    • Income (P&L)
    • Ratios

      • Employee & Interest Expense

        Company has spent 3.32% of its operating revenues towards interest expenses and 31.35% towards employee cost in the year ending Mar 31, 2025. (Source: Consolidated Financials)

      • ROE Outperforming 5 Year Average

        Company delivered ROE of 13.41% in year ending Mar 31, 2025 outperforming its 5 year avg. of 7.75%. (Source: Consolidated Financials)

    Do you find these insights useful?

    • hate it

    • meh

    • love it

    Jubilant Life Share Price Forecast

    • Get multiple analysts’ prediction on Jubilant Life

      Stock Forecast Non Prime User
      • High, low, medium predictions for Price
      • Upcoming predictions for Revenue
      • Details about company earnings
      START FREE TRIAL

    • Get multiple analysts’ prediction on Jubilant Life

      Stock Forecast Non Prime User
      • High, low, medium predictions for Price
      • Upcoming predictions for Revenue
      • Details about company earnings
      START FREE TRIAL

    • Get multiple analysts’ prediction on Jubilant Life

      Stock Forecast Non Prime User
      • High, low, medium predictions for Price
      • Upcoming predictions for Revenue
      • Details about company earnings
      START FREE TRIAL

    Jubilant Life Technicals